Jim Post is a Board member at Lunaphore and the President of Epredia, a PHC Group company focused on anatomical pathology.
Prior to joining Epredia, Jim spent four years at Thermo Fisher Scientific as the Vice President of Commercial Sales for the Anatomical Pathology Division, and then as President, leading the division and its sale to PHC Group. Jim has worked as Executive Vice President of Commercial Operations for the start-up Cepheid in Sunnyvale, CA, where he was responsible for rebuilding the commercial organization for sustainable growth.
Jim spent 12 years at Biosite/Inverness/Alere, where he led the global hospital business as President, Acute Care, which included diagnostic instrumentation, lateral flow devices, and connectivity software solutions. In this role Jim had management responsibility for five manufacturing facilities in US, Canada, and China and led three major acquisitions. He also spent 12 years in various sales roles for the healthcare instrument business with United States Surgical, which was acquired by Tyco.